Please ensure Javascript is enabled for purposes of website accessibility

Why Bausch Health Companies Stock Is Crashing Today

By George Budwell - Mar 12, 2020 at 12:03PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Bausch's shares are being pulled under by the marketwide sell-off today.

What happened

Shares of Bausch Health Companies (BHC 2.03%) are down by 13.2% as of 11:24 a.m. EDT Thursday morning. The multinational healthcare company is tanking today in response to the marketwide sell-off that's being fueled by COVID-19.

Yesterday, President Trump suspended flights between the U.S. and Europe for 30 days, and the NBA decided to pause its season for the moment as a result of the public health threat posed by COVID-19. These two events are spooking investors across the globe today. 

An elderly man undergoing an eye exam.

Image source: Getty Images.

So what

What's remarkable is that COVID-19 shouldn't have any material impact on Bausch's underlying business. The company makes the bulk of its money with eye care products and specialty pharmaceuticals like the irritable bowel syndrome medication Xifaxan. People aren't going to stop taking care of their eyes or treating their chronic illnesses because of a virus. What's more, Bausch's shares were already dirt cheap prior to today's sell-off. The company's shares are now trading at distressed asset levels based on its forward-looking price-to-sales ratio of just 0.62. 

Now what

Should bargain hunters pounce on this healthcare stock today? The answer is a resounding yes. While Bausch still has a long way to go to improve its balance sheet, the company should ultimately be able to complete this comeback within the next three to four years. Therefore there's no reason its shares should be trading at levels that would seem to suggest a bankruptcy filing is imminent. Bausch, after all, is on solid ground, and its future looks bright. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Bausch Health Companies Inc. Stock Quote
Bausch Health Companies Inc.
$8.53 (2.03%) $0.17

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/04/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.